SLC18B1

Model summary

A vesicle-localized, multi-pass transporter that uses the proton gradient established by V-type ATPases to exchange protons for cationic monoamines and polyamines. By concentrating serotonin, dopamine, norepinephrine, and polyamines within secretory and synaptic vesicles, it drives their vesicular uptake and storage, thereby governing neurotransmitter reuptake and availability for regulated exocytosis. Its alternating-access mechanism and vesicular specialization position it on secretory granule and cytoplasmic vesicle membranes, where it couples proton motive force to the accumulation of biogenic amines and polyamines.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide is dominated by the Major Facilitator Superfamily (MFS): IPR036259 (MFS transporter superfamily, homologous_superfamily, residues 24–440) envelops the core; within it sit IPR020846 (Major facilitator superfamily domain, residues 36–435) and IPR011701 (Major facilitator superfamily, family, residues 43–354), while IPR050930 (Major Facilitator Superfamily Vesicular Transporter, family, residues 28–440) specifies a vesicle-localized clade. This layered arrangement—broad MFS scaffold with vesicular-transporter specialization—implies a canonical 12-helix alternating-access fold that catalyzes secondary active transport. The vesicular-transporter family signature indicates coupling to the proton motive force generated by V-type ATPases on secretory and synaptic vesicles.

2. 02

   This MFS architecture dictates molecular function.

   The alternating-access core and vesicular specialization cause antiporter activity (GO:0015297), where proton gradients drive substrate exchange. Substrate scope is defined by the vesicular transporter family and known cationic substrates: polyamine and monoamine transmembrane transporter activities (GO:0015203 and GO:0008504). The mechanistic coupling to H+ gradients and exchange of intravesicular monoamines and polyamines is a hallmark of this vesicular MFS branch.

3. 03

   From function to process, proton-coupled exchange of monoamines and polyamines directly implements neurotransmitter reuptake (GO:0098810) into secretory and synaptic vesicles and supports serotonin transport (GO:0006837) and spermidine transport (GO:0015848).

   By loading aminergic transmitters and polyamines into vesicles, the transporter sets vesicular content that determines cytosol-to-vesicle flux and ultimately the availability of transmitters for regulated exocytosis.

4. 04

   Cellular location follows from both architecture and substrate flow.

   The vesicular transporter family and the requirement for a proton gradient point to membranes of intracellular vesicles energized by V-ATPase. This places the protein at the secretory granule membrane (GO:0030667) and more generally on cytoplasmic vesicle membranes. The multi-pass topology inferred from the MFS fold is consistent with a multi-pass membrane protein.

5. 05

   Mechanistically, the transporter likely operates via a proton/polyamine antiport cycle: protonation of luminal-facing residues primes an alternating-access transition that exchanges H+ for cationic substrates such as serotonin, dopamine, norepinephrine, and polyamines (spermine/spermidine).

   This cycle concentrates monoamines and polyamines into vesicles, tuning neuronal and endocrine signaling. I hypothesize that it forms transient complexes with vesicular V-ATPase subunits to sense and utilize the proton gradient, and with vesicle biogenesis and trafficking modules. Candidate partners include V-ATPase components that establish the driving force; vesicular biogenesis factors such as VAMP7 and VAMP8 that define secretory vesicles; adaptor and coat machinery like AP-3 and clathrin that sort vesicle cargo; and small GTPases such as RAB27A that govern granule docking and release. Together these interactions would coordinate gradient generation, vesicle identity, and substrate loading to control reuptake and storage of biogenic amines and polyamines.